ARCHIVES

GAO Report Refutes Charges Against Control Program

This article is from The Cancer Letter archive.

Vol. 06 No. 22 | May 30, 1980

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

NCI To Implement Recommendations, Sondik Says

September 2, 1988

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004

Indiana to Close Proton Beam Facility Amid Nationwide Building Boom

October 17, 2014

NCI CTEP Approved Trials For the Month of August

August 30, 2013

Antman, Clanton begin work at NCI.

December 5, 2003